Latest Datamonitor Stories
RA'ANANA, Israel, June 29 /PRNewswire-FirstCall/ -- NICE Systems (NASDAQ: NICE), a leading global provider of advanced solutions that enable organizations to extract insight from interactions to drive performance, today announced that leading industry analyst firm Datamonitor recognized NICE's worldwide leadership position in its 2009 contact center analytics market report "Decision Matrix: Selecting a Contact Center Analytics Vendor (Competitor Focus); Analytics and reporting as...
- New research identifies need for transparent communication, additional risk management disclosure and thoughtful regulation NEW YORK, June 22 /PRNewswire/ -- The investment management industry should work to rebuild trust with investors through a 'back-to-basics' client relationship approach, combining improved communication and education, increasing knowledge sharing, and bolstering corporate governance and risk management transparency, reports a new investment management survey entitled:...
Sales of hormone replacement therapy have declined recently due to safety concerns, giving non-hormonal drugs for menopausal symptoms an estimated revenue potential of over $535m across the US and five major EU markets in 2007.
Research and Markets (http://www.researchandmarkets.com/research/c84a4e/forecast_insight) has announced the addition of the "Forecast Insight: Parkinson's Disease - Market Upgrade following Evidence of Disease Slowing with Azilect" report to their offering.
Neurogen's new dopamine agonist aplindore has shown positive results in Phase II trials in the treatment of Parkinson's disease and restless leg syndrome. Datamonitor estimates dopamine agonist sales in these indications were worth $1.5 billion in 2007.
Although the credit crunch has left non-financial services companies, including those in the biotechnology industry, without cheap debt, the pharmaceutical industry avoided relying on this resource and has remained cash-rich.
Reportlinker.com announces that a new market research report related to the Pharmaceutical industry industry is available in its catalogue.
Reportlinker.com announces that a new market research report related to the Pharmaceutical industry is available in its catalogue.
Targeted therapies have improved treatment outcomes in cancer notably, becoming the leading therapy class in the oncology market. As a result, they are expected to achieve sales of over $42 billion by 2017.
Nasacort, a nasal steroid used in allergic rhinitis, has been approved for the treatment of children aged two to five years old.
- A volcanic mudflow.